Colgate-Palmolive (CL) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.99
- EPS estimate
- $0.95
- EPS surprise
- +4.54%
- Revenue surprise
- +0.09%
- Revenue
- $5.4B
- Revenue estimate
- $5.4B
- Reported
- Jul 31, 2026
Colgate-Palmolive reported Q2 2026 results on July 31, 2026. Earnings per share came in at $0.99, ahead of the $0.95 estimate by 4.54%. Revenue was $5.4 billion, 0.09% above the consensus. Compared with Q2 2025, EPS rose about 8% from $0.92 and revenue rose about 6% from $5.1 billion.
The longer record shows steady growth. Annual EPS rose from $2.97 in 2022 to $3.23 in 2023, $3.59 in 2024 and $3.69 in 2025, a gain of about 24% over three years. The first half of 2026 added $1.96, about 7% more than the same period a year earlier. Quarterly revenue climbed from $4.4 billion in late 2021 and early 2022 to $5.4 billion. Q2 2026 set the highs in the table for both EPS and revenue. The low was $0.72 per share, in Q2 2022. Over the last 20 quarters, Colgate-Palmolive topped the EPS estimate 19 times. The only miss was Q1 2022, at 0.60% below.
Colgate-Palmolive reported Q3 between October 25 and October 31 in each of the past five years. That points to late October 2026 for the next report. It will show whether the year-over-year growth seen in recent quarters continues.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 31, 2026 | $0.95 | $0.99 | +4.54% | $5.4B | SEC |
| Q1 2026 | May 1, 2026 | $0.94 | $0.97 | +2.83% | $5.3B | SEC |
| Q4 2025 | Jan 30, 2026 | $0.91 | $0.95 | +4.19% | $5.2B | SEC |
| Q3 2025 | Oct 31, 2025 | $0.89 | $0.91 | +2.35% | $5.1B | SEC |
| Q2 2025 | Aug 1, 2025 | $0.90 | $0.92 | +2.54% | $5.1B | SEC |
| Q1 2025 | Apr 25, 2025 | $0.86 | $0.91 | +6.32% | $4.9B | SEC |
| Q4 2024 | Jan 31, 2025 | $0.89 | $0.91 | +2.28% | $4.9B | SEC |
| Q3 2024 | Oct 25, 2024 | $0.89 | $0.91 | +2.81% | $5.0B | SEC |
| Q2 2024 | Jul 26, 2024 | $0.87 | $0.91 | +4.74% | $5.1B | SEC |
| Q1 2024 | Apr 26, 2024 | $0.81 | $0.86 | +5.81% | $5.1B | SEC |
| Q4 2023 | Jan 26, 2024 | $0.85 | $0.87 | +2.16% | $5.0B | SEC |
| Q3 2023 | Oct 27, 2023 | $0.80 | $0.86 | +7.26% | $4.9B | SEC |
| Q2 2023 | Jul 28, 2023 | $0.75 | $0.77 | +3.24% | $4.8B | SEC |
| Q1 2023 | Apr 28, 2023 | $0.70 | $0.73 | +4.27% | $4.8B | SEC |
| Q4 2022 | Jan 27, 2023 | $0.76 | $0.77 | +0.72% | $4.6B | SEC |
| Q3 2022 | Oct 28, 2022 | $0.73 | $0.74 | +1.08% | $4.5B | — |
| Q2 2022 | Jul 29, 2022 | $0.71 | $0.72 | +1.48% | $4.5B | — |
| Q1 2022 | Apr 29, 2022 | $0.74 | $0.74 | −0.60% | $4.4B | — |
| Q4 2021 | Jan 28, 2022 | $0.79 | $0.79 | +0.43% | $4.4B | — |
| Q3 2021 | Oct 29, 2021 | $0.80 | $0.81 | +1.84% | $4.4B | — |
Quarterly revenue
Frequently asked questions
When did Colgate-Palmolive (CL) last report earnings?
Colgate-Palmolive last reported on Jul 31, 2026, covering fiscal Q2 2026.
Did CL beat earnings estimates?
Yes. Colgate-Palmolive reported EPS of $0.99 for Q2 2026 against a $0.95 estimate — a 4.54% beat.
How much revenue did CL report last quarter?
Colgate-Palmolive reported $5.4B in revenue for Q2 2026, against a consensus estimate of $5.4B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.